[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Hormonal drugs In-Depth Research Report 2017-2022

July 2017 | 124 pages | ID: GAF4DF5889CEN
US Market Insights (UMI)

US$ 3,190.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Hormonal drugs industry.
Major Companies
  • Alcon NV
  • Allergan Pharmaceuticals Ireland
  • AstraZeneca Pty Ltd
  • Bausch & Lomb Incorporated
  • BEECHAM GROUP PLC
  • Berlin-Chemie AG
  • Biofer S.p.A.
  • Bright Future Pharmaceuticals Factory
  • Chiesi Farmaceutici S.p.A.
  • FARMABIOS S.P.A.
  • GLAXO WELLCOME UK LIMITED
  • GlaxoSmithKline Australia Pty Ltd
  • Herbrand PharmaChemicals GmbH
  • Laboratoire GlaxoSmithKline
  • LEO Pharma A/S
  • Merck Serono GmbH
  • Mitsubishi Tanabe Pharma Corporation
  • MSD Merck Sharp & Dohme AG
  • NANG KUANG PHARMCEUTICAL CO., LTD
  • Newchem S.p.A.
  • NEWCHEM SPA
  • Orion Corporation
  • Pfizer Italia s.r.l
  • Pharmacia & Upjohn Co.,
  • SAMCHUNDANG PHARM. CO.,LTD.
  • Santen Pharmaceutical Co.,Ltd.
  • Sicor Societa’ Italiana Corticosteroidi S.R.L
  • SYNMOSA BIOPHARMA CORPORATION
Key Regions
  • North America
    • United States
      • California
      • Texas
      • New York
      • Others
    • Canada
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Netherland
    • Others
  • Asia & Pacific
    • China
    • Japan
    • India
    • Korea
    • Australia
    • Southeast Asia
      • Indonesia
      • Thailand
      • Philippines
      • Vietnam
      • Singapore
      • Malaysia
      • Others
  • Africa & Middle East
    • South Africa
    • Egypt
    • Turkey
    • Saudi Arabia
    • Iran
    • Others
Main types of products

Hormonal drugs Market, by Glucocorticoid
Cortisone
Hydrocortisone
Cortisol
Hydrocortisone Butyrate
Budesonide
Ciclesonide
Deflazacort
Medrysone
Tixocortol
Cloprednol
Halcinonide
Rimexolone
Flunisolide
Trianmcinolon
Amcinonide
Fluocinonide
Meprednisone
Fluorometholone
Fluocortolone
Fluocortin
Desoximetasone
Methylprednisolone
Prednicarbate
Prednylidene
Ciclesonide
Fluprednisolone
Dexamethasone
Betamethasone
Clobetasol
Clobetasone
Diflorasone
Fluperolone
Halometasone
Ulobetasol
Beclomethasone
Paramethasone
Alclometasone
Fluclorolone acetonide
Fluprednidene
Cortivazol
Fluticasone
Loteprednol
Fludroxycortide
Formocortal
Mometasone
Hormonal drugs Market, by Mineralocorticoids
Fludrocortisone
Aldosterone
Hormonal drugs Market, by Aldosterone receptor antagoni
Spironolactone
Eplerenone
Canrenoate Potassium
Canrenone
Hormonal drugs Market, by Synthetic modifier
Trilostane
Carbenoxolone
Aminoglutethimide
Metyrapone
Hormonal drugs Market, by Thyroid hormone and thyroid m
Thyroid Tablets
Liothyronine
Levothyroxine sodium
Methylthiouracil
Carbimazole
Methimazole
Propylthiouracil
Lugol's solution
Propranolol
Hormonal drugs Market, by Key Consumers
  • Pharmacy
  • Hospital
  • Department of endocrinology
  • Department of dermatology
  • infectious disease department
Global and United States Hormonal drugs In-Depth Research Report 2017-2022

CHAPTER ONE GLOBAL HORMONAL DRUGS MARKET OVERVIEW

1.1 Global Hormonal drugs Market Sales Volume Revenue and Price 2012-2017
1.2 Hormonal drugs, by Glucocorticoid 2012-2017
  1.2.1 Global Hormonal drugs Sales Market Share by Glucocorticoid 2012-2017
  1.2.2 Global Hormonal drugs Revenue Market Share by Glucocorticoid 2012-2017
  1.2.3 Global Hormonal drugs Price by Glucocorticoid 2012-2017
1.3 Hormonal drugs, by Mineralocorticoids 2012-2017
  1.3.1 Global Hormonal drugs Sales Market Share by Mineralocorticoids 2012-2017
  1.3.2 Global Hormonal drugs Revenue Market Share by Mineralocorticoids 2012-2017
  1.3.3 Global Hormonal drugs Price by Mineralocorticoids 2012-2017
1.4 Hormonal drugs, by Aldosterone receptor antagonis 2012-2017
  1.4.1 Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis 2012-2017
  1.4.2 Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis 2012-2017
  1.4.3 Global Hormonal drugs Price by Aldosterone receptor antagonis 2012-2017
1.5 Hormonal drugs, by Synthetic modifier 2012-2017
  1.5.1 Global Hormonal drugs Sales Market Share by Synthetic modifier 2012-2017
  1.5.2 Global Hormonal drugs Revenue Market Share by Synthetic modifier 2012-2017
  1.5.3 Global Hormonal drugs Price by Synthetic modifier 2012-2017
1.6 Hormonal drugs, by Thyroid hormone and thyroid me 2012-2017
  1.6.1 Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me 2012-2017
  1.6.2 Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me 2012-2017
  1.6.3 Global Hormonal drugs Price by Thyroid hormone and thyroid me 2012-2017

CHAPTER TWO UNITED STATES HORMONAL DRUGS MARKET OVERVIEW

2.1 United States Hormonal drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Hormonal drugs, by Glucocorticoid 2012-2017
  2.2.1 United States Hormonal drugs Sales Market Share by Glucocorticoid 2012-2017
  2.2.2 United States Hormonal drugs Revenue Market Share by Glucocorticoid 2012-2017
  2.2.3 United States Hormonal drugs Price by Glucocorticoid 2012-2017
2.3 Hormonal drugs, by Mineralocorticoids 2012-2017
  2.3.1 United States Hormonal drugs Sales Market Share by Mineralocorticoids 2012-2017
  2.3.2 United States Hormonal drugs Revenue Market Share by Mineralocorticoids 2012-2017
  2.3.3 United States Hormonal drugs Price by Mineralocorticoids 2012-2017
2.4 Hormonal drugs, by Aldosterone receptor antagonis 2012-2017
  2.4.1 United States Hormonal drugs Sales Market Share by Aldosterone receptor antagonis 2012-2017
  2.4.2 United States Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis 2012-2017
  2.4.3 United States Hormonal drugs Price by Aldosterone receptor antagonis 2012-2017
2.5 Hormonal drugs, by Synthetic modifier 2012-2017
  2.5.1 United States Hormonal drugs Sales Market Share by Synthetic modifier 2012-2017
  2.5.2 United States Hormonal drugs Revenue Market Share by Synthetic modifier 2012-2017
  2.5.3 United States Hormonal drugs Price by Synthetic modifier 2012-2017
2.6 Hormonal drugs, by Thyroid hormone and thyroid me 2012-2017
  2.6.1 United States Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me 2012-2017
  2.6.2 United States Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me 2012-2017
  2.6.3 United States Hormonal drugs Price by Thyroid hormone and thyroid me 2012-2017

CHAPTER THREE HORMONAL DRUGS BY REGIONS 2012-2017

3.1 Global Hormonal drugs Sales Market Share by Regions 2012-2017
3.2 Global Hormonal drugs Revenue Market Share by Regions 2012-2017
3.3 Global Hormonal drugs Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL HORMONAL DRUGS BY COMPANIES 2012-2017

4.1 Global Hormonal drugs Sales Volume Market Share by Companies 2012-2017
4.2 Global Hormonal drugs Revenue Share by Companies 2012-2017
4.3 Global Top Companies Hormonal drugs Key Product Model and Market Performance
4.4 Global Top Companies Hormonal drugs Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES HORMONAL DRUGS BY COMPANIES 2012-2017

5.1 United States Hormonal drugs Sales Volume Market Share by Companies 2012-2017
5.2 United States Hormonal drugs Revenue Share by Companies 2012-2017
5.3 United States Top Companies Hormonal drugs Key Product Model and Market Performance
5.4 United States Top Companies Hormonal drugs Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL HORMONAL DRUGS BY CONSUMER 2012-2017

6.1 Global Hormonal drugs Sales Market Share by Consumer 2012-2017
6.2 Pharmacy
6.3 Hospital
6.4 Department of endocrinology
6.5 Department of dermatology
6.6 infectious disease department
6.7 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL HORMONAL DRUGS BY CONSUMER 2012-2017

7.1 Global Hormonal drugs Sales Market Share by Consumer 2012-2017
7.2 Pharmacy
7.3 Hospital
7.4 Department of endocrinology
7.5 Department of dermatology
7.6 infectious disease department
7.7 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 Alcon NV
  8.1.1 Alcon NV Company Details and Competitors
  8.1.2 Alcon NV Key Hormonal drugs Models and Performance
  8.1.3 Alcon NV Hormonal drugs Business SWOT Analysis and Forecast
  8.1.4 Alcon NV Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.2 Allergan Pharmaceuticals Ireland
  8.2.1 Allergan Pharmaceuticals Ireland Company Details and Competitors
  8.2.2 Allergan Pharmaceuticals Ireland Key Hormonal drugs Models and Performance
  8.2.3 Allergan Pharmaceuticals Ireland Hormonal drugs Business SWOT Analysis and Forecast
  8.2.4 Allergan Pharmaceuticals Ireland Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.3 AstraZeneca Pty Ltd
  8.3.1 AstraZeneca Pty Ltd Company Details and Competitors
  8.3.2 AstraZeneca Pty Ltd Key Hormonal drugs Models and Performance
  8.3.3 AstraZeneca Pty Ltd Hormonal drugs Business SWOT Analysis and Forecast
  8.3.4 AstraZeneca Pty Ltd Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.4 Bausch & Lomb Incorporated
  8.4.1 Bausch & Lomb Incorporated Company Details and Competitors
  8.4.2 Bausch & Lomb Incorporated Key Hormonal drugs Models and Performance
  8.4.3 Bausch & Lomb Incorporated Hormonal drugs Business SWOT Analysis and Forecast
  8.4.4 Bausch & Lomb Incorporated Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.5 BEECHAM GROUP PLC
  8.5.1 BEECHAM GROUP PLC Company Details and Competitors
  8.5.2 BEECHAM GROUP PLC Key Hormonal drugs Models and Performance
  8.5.3 BEECHAM GROUP PLC Hormonal drugs Business SWOT Analysis and Forecast
  8.5.4 BEECHAM GROUP PLC Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.6 Berlin-Chemie AG
  8.6.1 Berlin-Chemie AG Company Details and Competitors
  8.6.2 Berlin-Chemie AG Key Hormonal drugs Models and Performance
  8.6.3 Berlin-Chemie AG Hormonal drugs Business SWOT Analysis and Forecast
  8.6.4 Berlin-Chemie AG Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.7 Biofer S.p.A.
  8.7.1 Biofer S.p.A. Company Details and Competitors
  8.7.2 Biofer S.p.A. Key Hormonal drugs Models and Performance
  8.7.3 Biofer S.p.A. Hormonal drugs Business SWOT Analysis and Forecast
  8.7.4 Biofer S.p.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.8 Bright Future Pharmaceuticals Factory
  8.8.1 Bright Future Pharmaceuticals Factory Company Details and Competitors
  8.8.2 Bright Future Pharmaceuticals Factory Key Hormonal drugs Models and Performance
  8.8.3 Bright Future Pharmaceuticals Factory Hormonal drugs Business SWOT Analysis and Forecast
  8.8.4 Bright Future Pharmaceuticals Factory Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.9 Chiesi Farmaceutici S.p.A.
  8.9.1 Chiesi Farmaceutici S.p.A. Company Details and Competitors
  8.9.2 Chiesi Farmaceutici S.p.A. Key Hormonal drugs Models and Performance
  8.9.3 Chiesi Farmaceutici S.p.A. Hormonal drugs Business SWOT Analysis and Forecast
  8.9.4 Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.10 FARMABIOS S.P.A.
  8.10.1 FARMABIOS S.P.A. Company Details and Competitors
  8.10.2 FARMABIOS S.P.A. Key Hormonal drugs Models and Performance
  8.10.3 FARMABIOS S.P.A. Hormonal drugs Business SWOT Analysis and Forecast
  8.10.4 FARMABIOS S.P.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin
8.11 GLAXO WELLCOME UK LIMITED
8.12 GlaxoSmithKline Australia Pty Ltd
8.13 Herbrand PharmaChemicals GmbH
8.14 Laboratoire GlaxoSmithKline
8.15 LEO Pharma A/S
8.16 Merck Serono GmbH
8.17 Mitsubishi Tanabe Pharma Corporation
8.18 MSD Merck Sharp & Dohme AG
8.19 NANG KUANG PHARMCEUTICAL CO., LTD
8.20 Newchem S.p.A.
8.21 NEWCHEM SPA
8.22 Orion Corporation
8.23 Pfizer Italia s.r.l
8.24 Pharmacia & Upjohn Co.,
8.25 SAMCHUNDANG PHARM. CO.,LTD.
8.26 Santen Pharmaceutical Co.,Ltd.
8.27 Sicor Societa’ Italiana Corticosteroidi S.R.L
8.28 SYNMOSA BIOPHARMA CORPORATION

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 Hormonal drugs Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 Hormonal drugs Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL HORMONAL DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Hormonal drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Hormonal drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Hormonal drugs Sales () Forecast by Application (2017-2022)
10.4 Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
10.5 Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
10.6 Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
10.7 Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
10.8 Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)

CHAPTER ELEVEN UNITED STATES HORMONAL DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States Hormonal drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Hormonal drugs Sales () Forecast by Regions (2017-2022)
11.3 United States Hormonal drugs Sales () Forecast by Application (2017-2022)
11.4 United States Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
11.5 United States Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
11.6 United States Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
11.7 United States Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
11.8 United States Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES

Table Global Hormonal drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Hormonal drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Hormonal drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Glucocorticoid (2012-2017)
Table Global Hormonal drugs Sales Market Share by Glucocorticoid (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Glucocorticoid in 2016
Table Global Hormonal drugs Revenue (Million USD) by Glucocorticoid (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Glucocorticoid (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Glucocorticoid in 2016
Table Global Hormonal drugs Price () by Glucocorticoid (2012-2017)
Table Top Companies of Cortisone Hormonal drugs Products List
Figure Global Cortisone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Mineralocorticoids (2012-2017)
Table Global Hormonal drugs Sales Market Share by Mineralocorticoids (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Mineralocorticoids in 2016
Table Global Hormonal drugs Revenue (Million USD) by Mineralocorticoids (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Mineralocorticoids (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Mineralocorticoids in 2016
Table Global Hormonal drugs Price () by Mineralocorticoids (2012-2017)
Table Top Companies of Fludrocortisone Hormonal drugs Products List
Figure Global Fludrocortisone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Aldosterone receptor antagonis (2012-2017)
Table Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis in 2016
Table Global Hormonal drugs Revenue (Million USD) by Aldosterone receptor antagonis (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis in 2016
Table Global Hormonal drugs Price () by Aldosterone receptor antagonis (2012-2017)
Table Top Companies of Spironolactone Hormonal drugs Products List
Figure Global Spironolactone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Synthetic modifier (2012-2017)
Table Global Hormonal drugs Sales Market Share by Synthetic modifier (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Synthetic modifier in 2016
Table Global Hormonal drugs Revenue (Million USD) by Synthetic modifier (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Synthetic modifier (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Synthetic modifier in 2016
Table Global Hormonal drugs Price () by Synthetic modifier (2012-2017)
Table Top Companies of Trilostane Hormonal drugs Products List
Figure Global Trilostane Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Thyroid hormone and thyroid me (2012-2017)
Table Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me in 2016
Table Global Hormonal drugs Revenue (Million USD) by Thyroid hormone and thyroid me (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me in 2016
Table Global Hormonal drugs Price () by Thyroid hormone and thyroid me (2012-2017)
Table Top Companies of Thyroid Tablets Hormonal drugs Products List
Figure Global Thyroid Tablets Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure United States Hormonal drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Hormonal drugs Sales Volume () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Glucocorticoid (2012-2017)
Table United States Hormonal drugs Sales Market Share by Glucocorticoid (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Glucocorticoid in 2016
Table United States Hormonal drugs Revenue (Million USD) by Glucocorticoid (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Glucocorticoid (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Glucocorticoid in 2016
Table United States Hormonal drugs Price () by Glucocorticoid (2012-2017)
Table Top Companies of Cortisone Hormonal drugs Products List
Figure United States Cortisone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Mineralocorticoids (2012-2017)
Table United States Hormonal drugs Sales Market Share by Mineralocorticoids (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Mineralocorticoids in 2016
Table United States Hormonal drugs Revenue (Million USD) by Mineralocorticoids (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Mineralocorticoids (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Mineralocorticoids in 2016
Table United States Hormonal drugs Price () by Mineralocorticoids (2012-2017)
Table Top Companies of Fludrocortisone Hormonal drugs Products List
Figure United States Fludrocortisone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Aldosterone receptor antagonis (2012-2017)
Table United States Hormonal drugs Sales Market Share by Aldosterone receptor antagonis (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Aldosterone receptor antagonis in 2016
Table United States Hormonal drugs Revenue (Million USD) by Aldosterone receptor antagonis (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis in 2016
Table United States Hormonal drugs Price () by Aldosterone receptor antagonis (2012-2017)
Table Top Companies of Spironolactone Hormonal drugs Products List
Figure United States Spironolactone Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Synthetic modifier (2012-2017)
Table United States Hormonal drugs Sales Market Share by Synthetic modifier (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Synthetic modifier in 2016
Table United States Hormonal drugs Revenue (Million USD) by Synthetic modifier (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Synthetic modifier (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Synthetic modifier in 2016
Table United States Hormonal drugs Price () by Synthetic modifier (2012-2017)
Table Top Companies of Trilostane Hormonal drugs Products List
Figure United States Trilostane Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Thyroid hormone and thyroid me (2012-2017)
Table United States Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me in 2016
Table United States Hormonal drugs Revenue (Million USD) by Thyroid hormone and thyroid me (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me in 2016
Table United States Hormonal drugs Price () by Thyroid hormone and thyroid me (2012-2017)
Table Top Companies of Thyroid Tablets Hormonal drugs Products List
Figure United States Thyroid Tablets Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales () by Regions (2012-2017)
Table Global Hormonal drugs Sales Share by Regions (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Regions in 2016
Figure Global Hormonal drugs Sales Market Share by Regions in 2017
Table Global Hormonal drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Regions (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Regions in 2016
Figure Global Hormonal drugs Revenue Market Share by Regions in 2017
Table Global Hormonal drugs Price () by Regions (2012-2017)
Table North America Hormonal drugs Sales () by Regions (2012-2017)
Table North America Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Regions (2012-2017)
Table United States Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure United States Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Latin America Hormonal drugs Sales () by Regions (2012-2017)
Table Latin America Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Europe Hormonal drugs Sales () by Regions (2012-2017)
Table Europe Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Hormonal drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Hormonal drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Hormonal drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Global Hormonal drugs Sales Volume () by Major Companies (2012-2017)
Table Global Hormonal drugs Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Hormonal drugs Sales Volume Market Share by Major Companies 2016
Figure Global Hormonal drugs Sales Volume Market Share by Major Companies 2017
Table Global Hormonal drugs Revenue (Million USD) by Major Companies (2012-2017)
Table Global Hormonal drugs Revenue Market Share by Major Companies (2012-2017)
Figure Global Hormonal drugs Revenue Market Share by Major Companies 2016
Figure Global Hormonal drugs Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Hormonal drugs Sales Volume () by Top Companies (2012-2017)
Table United States Hormonal drugs Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Hormonal drugs Sales Volume Market Share by Top Companies 2016
Figure United States Hormonal drugs Sales Volume Market Share by Top Companies 2017
Table United States Hormonal drugs Revenue (Million USD) by Top Companies (2012-2017)
Table United States Hormonal drugs Revenue Market Share by Top Companies (2012-2017)
Figure United States Hormonal drugs Revenue Market Share by Top Companies 2016
Figure United States Hormonal drugs Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Hormonal drugs Sales () by Consumer (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Consumer (2012-2017)
Figure Global Hormonal drugs Sales Market Share by Consumer in 2016
Figure Global Pharmacy Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure Global Department of endocrinology Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure Global Department of dermatology Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure Global infectious disease department Hormonal drugs Sales () and Growth Rate (2012-2017)
Table United States Hormonal drugs Sales () by Consumer (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Consumer (2012-2017)
Figure United States Hormonal drugs Sales Market Share by Consumer in 2016
Figure United States Pharmacy Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure United States Hospital Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure United States Department of endocrinology Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure United States Department of dermatology Hormonal drugs Sales () and Growth Rate (2012-2017)
Figure United States infectious disease department Hormonal drugs Sales () and Growth Rate (2012-2017)
Table Alcon NV Company Details and Competitors
Table Alcon NV Key Hormonal drugs Models and Performance
Table Alcon NV Hormonal drugs Business SWOT Analysis and Forecast
Table Alcon NV Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Alcon NV Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Alcon NV Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Alcon NV Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Alcon NV Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Allergan Pharmaceuticals Ireland Company Details and Competitors
Table Allergan Pharmaceuticals Ireland Key Hormonal drugs Models and Performance
Table Allergan Pharmaceuticals Ireland Hormonal drugs Business SWOT Analysis and Forecast
Table Allergan Pharmaceuticals Ireland Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Allergan Pharmaceuticals Ireland Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table AstraZeneca Pty Ltd Company Details and Competitors
Table AstraZeneca Pty Ltd Key Hormonal drugs Models and Performance
Table AstraZeneca Pty Ltd Hormonal drugs Business SWOT Analysis and Forecast
Table AstraZeneca Pty Ltd Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AstraZeneca Pty Ltd Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AstraZeneca Pty Ltd Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure AstraZeneca Pty Ltd Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AstraZeneca Pty Ltd Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Bausch & Lomb Incorporated Company Details and Competitors
Table Bausch & Lomb Incorporated Key Hormonal drugs Models and Performance
Table Bausch & Lomb Incorporated Hormonal drugs Business SWOT Analysis and Forecast
Table Bausch & Lomb Incorporated Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Bausch & Lomb Incorporated Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Bausch & Lomb Incorporated Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Bausch & Lomb Incorporated Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Bausch & Lomb Incorporated Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table BEECHAM GROUP PLC Company Details and Competitors
Table BEECHAM GROUP PLC Key Hormonal drugs Models and Performance
Table BEECHAM GROUP PLC Hormonal drugs Business SWOT Analysis and Forecast
Table BEECHAM GROUP PLC Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BEECHAM GROUP PLC Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BEECHAM GROUP PLC Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure BEECHAM GROUP PLC Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BEECHAM GROUP PLC Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Berlin-Chemie AG Company Details and Competitors
Table Berlin-Chemie AG Key Hormonal drugs Models and Performance
Table Berlin-Chemie AG Hormonal drugs Business SWOT Analysis and Forecast
Table Berlin-Chemie AG Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Berlin-Chemie AG Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Berlin-Chemie AG Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Berlin-Chemie AG Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Berlin-Chemie AG Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Biofer S.p.A. Company Details and Competitors
Table Biofer S.p.A. Key Hormonal drugs Models and Performance
Table Biofer S.p.A. Hormonal drugs Business SWOT Analysis and Forecast
Table Biofer S.p.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Biofer S.p.A. Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Biofer S.p.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Biofer S.p.A. Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Biofer S.p.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Bright Future Pharmaceuticals Factory Company Details and Competitors
Table Bright Future Pharmaceuticals Factory Key Hormonal drugs Models and Performance
Table Bright Future Pharmaceuticals Factory Hormonal drugs Business SWOT Analysis and Forecast
Table Bright Future Pharmaceuticals Factory Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Bright Future Pharmaceuticals Factory Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table Chiesi Farmaceutici S.p.A. Company Details and Competitors
Table Chiesi Farmaceutici S.p.A. Key Hormonal drugs Models and Performance
Table Chiesi Farmaceutici S.p.A. Hormonal drugs Business SWOT Analysis and Forecast
Table Chiesi Farmaceutici S.p.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table FARMABIOS S.P.A. Company Details and Competitors
Table FARMABIOS S.P.A. Key Hormonal drugs Models and Performance
Table FARMABIOS S.P.A. Hormonal drugs Business SWOT Analysis and Forecast
Table FARMABIOS S.P.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure FARMABIOS S.P.A. Hormonal drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure FARMABIOS S.P.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)
Figure FARMABIOS S.P.A. Hormonal drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure FARMABIOS S.P.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)
Table GLAXO WELLCOME UK LIMITED Company Details and Competitors
Table GlaxoSmithKline Australia Pty Ltd Company Details and Competitors
Table Herbrand PharmaChemicals GmbH Company Details and Competitors
Table Laboratoire GlaxoSmithKline Company Details and Competitors
Table LEO Pharma A/S Company Details and Competitors
Table Merck Serono GmbH Company Details and Competitors
Table Mitsubishi Tanabe Pharma Corporation Company Details and Competitors
Table MSD Merck Sharp & Dohme AG Company Details and Competitors
Table NANG KUANG PHARMCEUTICAL CO., LTD Company Details and Competitors
Table Newchem S.p.A. Company Details and Competitors
Table NEWCHEM SPA Company Details and Competitors
Table Orion Corporation Company Details and Competitors
Table Pfizer Italia s.r.l Company Details and Competitors
Table Pharmacia & Upjohn Co., Company Details and Competitors
Table SAMCHUNDANG PHARM. CO.,LTD. Company Details and Competitors
Table Santen Pharmaceutical Co.,Ltd. Company Details and Competitors
Table Sicor Societa’ Italiana Corticosteroidi S.R.L Company Details and Competitors
Table SYNMOSA BIOPHARMA CORPORATION Company Details and Competitors
Figure Global Hormonal drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Hormonal drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hormonal drugs Price () Trend Forecast (2017-2022)
Table Global Hormonal drugs Sales () Forecast by Regions (2017-2022)
Table Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Hormonal drugs Sales Volume Share Forecast by Regions in 2022
Table Global Hormonal drugs Sales () Forecast by Application (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
Figure Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Glucocorticoid in 2022
Table Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
Figure Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Mineralocorticoids in 2022
Table Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
Figure Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Aldosterone receptor antagonis in 2022
Table Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
Figure Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Synthetic modifier in 2022
Table Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)
Figure Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)
Figure Global Hormonal drugs Sales Volume Market Share Forecast by Thyroid hormone and thyroid me in 2022
Figure United States Hormonal drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure United States Hormonal drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hormonal drugs Price () Trend Forecast (2017-2022)
Table United States Hormonal drugs Sales () Forecast by Regions (2017-2022)
Table United States Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Hormonal drugs Sales Volume Share Forecast by Regions in 2022
Table United States Hormonal drugs Sales () Forecast by Application (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Application in 2022
Table United States Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
Figure United States Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Glucocorticoid in 2022
Table United States Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
Figure United States Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Mineralocorticoids in 2022
Table United States Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
Figure United States Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Aldosterone receptor antagonis in 2022
Table United States Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
Figure United States Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Synthetic modifier in 2022
Table United States Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)
Figure United States Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)
Figure United States Hormonal drugs Sales Volume Market Share Forecast by Thyroid hormone and thyroid me in 2022


More Publications